These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 9830322
1. [Intermittent interferon alfa in the treatment of hairy cell leukemia]. Gómez-Almaguer D, Jaime-Pérez JC, Herrera-Garza JL, González-Llano O. Rev Invest Clin; 1998; 50(4):331-4. PubMed ID: 9830322 [Abstract] [Full Text] [Related]
2. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin]. Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D. Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434 [Abstract] [Full Text] [Related]
3. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study. Johnston JB, Eisenhauer E, Wainman N, Corbett WE, Zaentz SD, Daeninck PJ. Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049 [Abstract] [Full Text] [Related]
4. Hairy-cell leukemia and alpha-interferon treatment: long-term responders. Zinzani PL, Lauria F, Salvucci M, Rondelli D, Raspadori D, Bendandi M, Magagnoli M, Tura S. Haematologica; 1997 Apr; 82(2):152-5. PubMed ID: 9175317 [Abstract] [Full Text] [Related]
5. Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia. Benz R, Siciliano RD, Stussi G, Fehr J. Eur J Haematol; 2009 Mar; 82(3):194-200. PubMed ID: 19077050 [Abstract] [Full Text] [Related]
6. Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine. Zaja F, Fanin R, Silvestri F, Russo D, Infanti L, Baccarani M. Haematologica; 1997 Mar; 82(4):468-70. PubMed ID: 9299866 [Abstract] [Full Text] [Related]
8. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications. Lauria F, Bocchia M, Marotta G, Raspadori D, Zinzani PL, Rondelli D. Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389 [Abstract] [Full Text] [Related]
9. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine). Füreder W, Weltermann A, Chott A, Gisslinger H, Valent P, Jäger U, Geissler K, Lechner K. Wien Klin Wochenschr; 1999 Dec 23; 111(24):1027-30. PubMed ID: 10677889 [Abstract] [Full Text] [Related]
10. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment. Babuŝíková O, Tomová A, Kusenda J, Gyárfás J. Neoplasma; 2001 Dec 23; 48(5):350-7. PubMed ID: 11845978 [Abstract] [Full Text] [Related]
19. Early response to alpha interferon in a patient affected by hairy cell leukemia. Di Raimondo F, Murolo D, Milone G, Cacciola E, Giustolisi R. Haematologica; 1992 Sep 23; 77(4):355-6. PubMed ID: 1427445 [Abstract] [Full Text] [Related]
20. Treatment of hairy cell leukemia: long-term results in a developing country. Ruiz-Delgado GJ, Tarín-Arzaga LC, Alarcón-Urdaneta C, Calderón-García J, Gómez-Almaguer D, Ruiz-Argüelles GJ. Hematology; 2012 May 23; 17(3):140-3. PubMed ID: 22664112 [Abstract] [Full Text] [Related] Page: [Next] [New Search]